{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:10:44Z","timestamp":1784131844059,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00125-010-1698-8","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T21:38:34Z","timestamp":1268257114000},"page":"1217-1226","source":"Crossref","is-referenced-by-count":49,"title":["Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments"],"prefix":"10.1007","volume":"53","author":[{"given":"J.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Glyn-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Obolonkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Poppitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R. J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J. S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"1698_CR1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/diabetes.54.5.1468","volume":"54","author":"GJS Cooper","year":"2005","unstructured":"Cooper GJS, Chan YK, Dissanayake AM et al (2005) Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 54:1468\u20131476","journal-title":"Diabetes"},{"key":"1698_CR2","first-page":"441","volume":"42","author":"JM Walshe","year":"1973","unstructured":"Walshe JM (1973) Copper chelation in patients with Wilson\u2019s disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 42:441\u2013452","journal-title":"Q J Med"},{"key":"1698_CR3","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2337\/diabetes.53.9.2501","volume":"53","author":"GJS Cooper","year":"2004","unstructured":"Cooper GJS, Phillips ARJ, Choong SY et al (2004) Regeneration of the heart in diabetes by selective copper chelation. Diabetes 53:2501\u20132508","journal-title":"Diabetes"},{"key":"1698_CR4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/mol.106.028605","volume":"70","author":"D Gong","year":"2006","unstructured":"Gong D, Lu J, Chen X et al (2006) Molecular changes evoked by triethylenetetramine (TETA) treatment in the extracellular matrix of the heart and aorta in diabetic rats. Mol Pharmacol 70:2045\u20132051","journal-title":"Mol Pharmacol"},{"key":"1698_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00125-009-1265-3","volume":"52","author":"GJS Cooper","year":"2009","unstructured":"Cooper GJS, Young AA, Gamble GD et al (2009) A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type-2 diabetic patients. Diabetologia 52:715\u2013722","journal-title":"Diabetologia"},{"key":"1698_CR6","doi-asserted-by":"crossref","first-page":"696378","DOI":"10.1155\/2009\/696378","volume":"2009","author":"JW Baynes","year":"2009","unstructured":"Baynes JW, Murray DB (2009) The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic rat. Exp Diabetes Res 2009:696378","journal-title":"Exp Diabetes Res"},{"key":"1698_CR7","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/pmic.200900285","volume":"9","author":"D Gong","year":"2009","unstructured":"Gong D, Chen X, Middleditch M et al (2009) Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. Proteomics 9:4309\u20134320","journal-title":"Proteomics"},{"key":"1698_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0950-3579(05)80007-X","volume":"4","author":"DA Joyce","year":"1990","unstructured":"Joyce DA (1990) D-penicillamine. Bailli\u00e8res Clin Rheumatol 4:553\u2013574","journal-title":"Bailli\u00e8res Clin Rheumatol"},{"key":"1698_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1345\/aph.17075","volume":"32","author":"LA Anderson","year":"1998","unstructured":"Anderson LA, Hakojarvi SL, Boudreaux SK (1998) Zinc acetate treatment in Wilson\u2019s disease. Ann Pharmacother 32:78\u201387","journal-title":"Ann Pharmacother"},{"key":"1698_CR10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/14656566.2.9.1473","volume":"2","author":"GJ Brewer","year":"2001","unstructured":"Brewer GJ (2001) Zinc acetate for the treatment of Wilson\u2019s disease. Expert Opin Pharmacother 2:1473\u20131477","journal-title":"Expert Opin Pharmacother"},{"key":"1698_CR11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2174\/0929867043364685","volume":"11","author":"GJ Kontoghiorghes","year":"2004","unstructured":"Kontoghiorghes GJ, Pattichis K, Neocleous K, Kolnagou A (2004) The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects. Curr Med Chem 11:2161\u20132183","journal-title":"Curr Med Chem"},{"key":"1698_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1196\/annals.1345.019","volume":"1054","author":"A Piga","year":"2005","unstructured":"Piga A, Roggero S, Vinciguerra T, Sacchetti L, Gallo V, Longo F (2005) Deferiprone: new insight. Ann N Y Acad Sci 1054:169\u2013174","journal-title":"Ann N Y Acad Sci"},{"key":"1698_CR13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oso\/9780198508472.003.0016","volume-title":"The biological chemistry of the elements: the inorganic chemistry of life","author":"JJ Fra\u00fasto da Silva","year":"2001","unstructured":"Fra\u00fasto da Silva JJ, Williams RJ (2001) The biological chemistry of the elements: the inorganic chemistry of life. Clarendon, Oxford, pp 418\u2013435"},{"key":"1698_CR14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0008-6363(99)00169-8","volume":"43","author":"G Kojda","year":"1999","unstructured":"Kojda G, Harrison D (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43:562\u2013571","journal-title":"Cardiovasc Res"},{"key":"1698_CR15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","volume":"105","author":"T Guzik","year":"2002","unstructured":"Guzik T, Mussa S, Gastaldi D et al (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656\u20131662","journal-title":"Circulation"},{"key":"1698_CR16","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, Luscher TF, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108:1527\u20131532","journal-title":"Circulation"},{"key":"1698_CR17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI111550","volume":"74","author":"SL Marklund","year":"1984","unstructured":"Marklund SL (1984) Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 74:1398\u20131403","journal-title":"J Clin Invest"},{"key":"1698_CR18","first-page":"617","volume":"75","author":"TD Oury","year":"1996","unstructured":"Oury TD, Day BJ, Crapo JD (1996) Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest 75:617\u2013636","journal-title":"Lab Invest"},{"key":"1698_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0891-5849(03)00275-2","volume":"35","author":"CL Fattman","year":"2003","unstructured":"Fattman CL, Schaefer LM, Oury TD (2003) Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 35:236\u2013256","journal-title":"Free Radic Biol Med"},{"key":"1698_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(02)00419-1","volume":"1619","author":"P Stralin","year":"2003","unstructured":"Stralin P, Jacobsson H, Marklund SL (2003) Oxidative stress, NO\u2022 and smooth muscle cell extracellular superoxide dismutase expression. Biochim Biophys Acta 1619:1\u20138","journal-title":"Biochim Biophys Acta"},{"key":"1698_CR21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1042\/bj2940853","volume":"294","author":"J Sandstrom","year":"1993","unstructured":"Sandstrom J, Karlsson K, Edlund T, Marklund SL (1993) Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J 294:853\u2013857","journal-title":"Biochem J"},{"key":"1698_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2840-3-6","volume":"3","author":"IJ Edwards","year":"2004","unstructured":"Edwards IJ, Wagner JD, Vogl-Willis CA, Litwak KN, Cefalu WT (2004) Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys. Cardiovasc Diabetol 3:6","journal-title":"Cardiovasc Diabetol"},{"key":"1698_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbagen.2004.02.005","volume":"1672","author":"CA Vogl-Willis","year":"2004","unstructured":"Vogl-Willis CA, Edwards IJ (2004) High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim Biophys Acta 1672:36\u201345","journal-title":"Biochim Biophys Acta"},{"key":"1698_CR24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.RES.0000149568.85071.FB","volume":"95","author":"AD Nguyen","year":"2004","unstructured":"Nguyen AD, Itoh S, Jeney V et al (2004) Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res 95:1067\u20131074","journal-title":"Circ Res"},{"key":"1698_CR25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jinorgbio.2005.11.002","volume":"100","author":"H Zeng","year":"2006","unstructured":"Zeng H, Saari JT, Dahlen GM (2006) Copper deficiency increases fibulin-5 (DANCE\/EVEC) but decreases cytochrome C oxidase VIb subunit expression in rat heart. J Inorg Biochem 100:186\u2013191","journal-title":"J Inorg Biochem"},{"key":"1698_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.1992.81","volume":"41","author":"AB Roberts","year":"1992","unstructured":"Roberts AB, McCune BK, Dunn SR (1992) TGF-\u03b2: regulation of extracellular matrix. Kidney Int 41:557\u2013559","journal-title":"Kidney Int"},{"key":"1698_CR27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00004872-199816121-00011","volume":"16","author":"B Williams","year":"1998","unstructured":"Williams B (1998) Mechanical influences on vascular smooth muscle cell function. J Hypertens 16:1921\u20131929","journal-title":"J Hypertens"},{"key":"1698_CR28","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1016\/S0021-9258(19)50482-3","volume":"267","author":"SL Marklund","year":"1992","unstructured":"Marklund SL (1992) Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 267:6696\u20136701","journal-title":"J Biol Chem"},{"key":"1698_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/bbrc.1998.9326","volume":"250","author":"M Qian","year":"1998","unstructured":"Qian M, Liu M, Eaton JW (1998) Transition metals bind to glycated proteins forming redox active \u201cglycochelates\u201d: implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 250:385\u2013389","journal-title":"Biochem Biophys Res Commun"},{"key":"1698_CR30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00125-008-1088-7","volume":"51","author":"D Gong","year":"2008","unstructured":"Gong D, Lu J, Chen X et al (2008) A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-\u03b2 activation in the kidneys of rats used as a model of diabetes. Diabetologia 51:1741\u20131751","journal-title":"Diabetologia"},{"key":"1698_CR31","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/cg0704549","volume":"7","author":"KA Wichmann","year":"2007","unstructured":"Wichmann KA, Boyd PDW, S\u00f6hnel T, Allen GR, Phillips ARJ, Cooper GJS (2007) Characterization of dicarboxylic salts of protonated triethylenetetramine useful for the treatment of copper-related pathologies. Cryst Growth Des 7:1844\u20131850","journal-title":"Cryst Growth Des"},{"key":"1698_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2007.09.001","volume":"859","author":"J Lu","year":"2007","unstructured":"Lu J, Chan Y-K, Poppitt SD, Cooper GJS (2007) Determination of triethylenetetramine (TETA) and its metabolites in human plasma and urine by liquid chromatography\u2013mass spectrometry (LC-MS). J Chromatogr B: Anal Technol Biomed Life Sci 859:62\u201368","journal-title":"J Chromatogr B: Anal Technol Biomed Life Sci"},{"key":"1698_CR33","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"1999","unstructured":"Halliwell B, Gutteridge JM (1999) Free radicals in biology and medicine. Oxford University Press, Oxford"},{"key":"1698_CR34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardiores.2004.10.041","volume":"65","author":"J Martin","year":"2005","unstructured":"Martin J, Kelly DJ, Mifsud SA et al (2005) Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-\u03b2. Cardiovasc Res 65:694\u2013701","journal-title":"Cardiovasc Res"},{"key":"1698_CR35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2005.06.018","volume":"40","author":"D Jay","year":"2006","unstructured":"Jay D, Hitomi H, Griendling KK (2006) Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40:183\u2013192","journal-title":"Free Radic Biol Med"},{"key":"1698_CR36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/157016106777698469","volume":"4","author":"MA Haidara","year":"2006","unstructured":"Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA (2006) Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 4:215\u2013227","journal-title":"Curr Vasc Pharmacol"},{"key":"1698_CR37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.06.006","volume":"202","author":"JW Stephens","year":"2009","unstructured":"Stephens JW, Khanolkar MP, Bain SC (2009) The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202:321\u2013329","journal-title":"Atherosclerosis"},{"key":"1698_CR38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/157339909788166800","volume":"5","author":"M Friederich","year":"2009","unstructured":"Friederich M, Hansell P, Palm F (2009) Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 5:120\u2013144","journal-title":"Curr Diabetes Rev"},{"key":"1698_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0076-6879(02)49322-6","volume":"349","author":"SL Marklund","year":"2002","unstructured":"Marklund SL (2002) Extracellular superoxide dismutase. Methods Enzymol 349:74\u201380","journal-title":"Methods Enzymol"},{"key":"1698_CR40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/diab.44.10.1139","volume":"44","author":"K Sharma","year":"1995","unstructured":"Sharma K, Ziyadeh FN (1995) Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44:1139\u20131146","journal-title":"Diabetes"},{"key":"1698_CR41","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988\u2013998","journal-title":"Circ Res"},{"key":"1698_CR42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/13543784.14.5.557","volume":"14","author":"L Gullestad","year":"2005","unstructured":"Gullestad L, Kjekshus J, Damas JK, Ueland T, Yndestad A, Aukrust P (2005) Agents targeting inflammation in heart failure. Expert Opin Investig Drugs 14:557\u2013566","journal-title":"Expert Opin Investig Drugs"},{"key":"1698_CR43","doi-asserted-by":"crossref","first-page":"H106","DOI":"10.1152\/ajpheart.01327.2005","volume":"291","author":"K Kaur","year":"2006","unstructured":"Kaur K, Sharma AK, Singal PK (2006) Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291:H106\u2013H113","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1698_CR44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1999.00591.x","volume":"56","author":"H Yokoyama","year":"1999","unstructured":"Yokoyama H, Sato K, Okudaira M et al (1999) Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy. Kidney Int 56:650\u2013658","journal-title":"Kidney Int"},{"key":"1698_CR45","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0891-5849(00)00394-4","volume":"29","author":"A Ghiselli","year":"2000","unstructured":"Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106\u20131114","journal-title":"Free Radic Biol Med"},{"key":"1698_CR46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0891-5849(99)00203-8","volume":"27","author":"RL Prior","year":"1999","unstructured":"Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173\u20131181","journal-title":"Free Radic Biol Med"},{"key":"1698_CR47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0735-1097(99)00581-1","volume":"35","author":"A Buffon","year":"2000","unstructured":"Buffon A, Santini SA, Ramazzotti V et al (2000) Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia. J Am Coll Cardiol 35:633\u2013639","journal-title":"J Am Coll Cardiol"},{"key":"1698_CR48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jcp.54.5.339","volume":"54","author":"IS Young","year":"2001","unstructured":"Young IS (2001) Measurement of total antioxidant capacity. J Clin Pathol 54:339","journal-title":"J Clin Pathol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-010-1698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-010-1698-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-010-1698-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T01:20:44Z","timestamp":1711329644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-010-1698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1698"],"URL":"https:\/\/doi.org\/10.1007\/s00125-010-1698-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]}}}